source
- US biotech faces internal split over reliance on Chinese-developed drug candidatesEd Silverman's Pharmalittle column notes that US biotech firms are wrestling with how to treat Chinese partners, with some seeing them as collaborators and others as competitors. The column highli…
- Experts debate testing Merck’s Ervebo vaccine for DRC Ebola outbreak amid lack of approved shotThe Democratic Republic of the Congo confirmed a new Ebola outbreak at the end of May, making it the fourth largest on record. The virus is spreading in a conflict-affected region, complicating con…